Lonza Group AG (LZAGY)
OTCMKTS · Delayed Price · Currency is USD
70.73
-1.30 (-1.80%)
Jul 30, 2025, 1:44 PM EDT
Lonza Group AG Market Cap
Lonza Group AG has a market cap or net worth of $50.81 billion as of July 30, 2025. Its market cap has increased by 20.80% in one year.
Market Cap
50.81B
Enterprise Value
55.47B
Revenue
8.92B
Ranking
n/a
PE Ratio
55.12
Stock Price
$70.73
Market Cap Chart
Since November 1, 1999, Lonza Group AG's market cap has increased from 3.78B to 50.81B, an increase of 1,244.33%. That is a compound annual growth rate of 10.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 50.81B | 19.08% |
| Dec 30, 2024 | 42.67B | 36.74% |
| Dec 29, 2023 | 31.20B | -14.17% |
| Dec 30, 2022 | 36.35B | -41.26% |
| Dec 30, 2021 | 61.89B | 29.41% |
| Dec 30, 2020 | 47.82B | 76.56% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 584.53M |
| Glass House Brands | 415.24M |
| Nika Pharmaceuticals | 366.89M |
| Northwest Biotherapeutics | 349.54M |
| CytoDyn | 341.59M |